Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * |
Title | ESM |
Description | Welcome to ESM ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH More Welcome to ESM Biotech Welcome to ESM Biotech Welcome |
Keywords | N/A |
WebSite | esmbiotech.co.uk |
Host IP | 160.153.136.3 |
Location | United States |
Site | Rank |
US$1,194
Last updated: 2022-11-01 21:39:42
esmbiotech.co.uk has Semrush global rank of 0. esmbiotech.co.uk has an estimated worth of US$ 1,194, based on its estimated Ads revenue. esmbiotech.co.uk receives approximately 137 unique visitors each day. Its web server is located in United States, with IP address 160.153.136.3. According to SiteAdvisor, esmbiotech.co.uk is safe to visit. |
Purchase/Sale Value | US$1,194 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$33 |
Yearly Ads Revenue | US$396 |
Daily Unique Visitors | 9 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
esmbiotech.co.uk. | A | 600 | IP: 160.153.136.3 |
esmbiotech.co.uk. | NS | 3600 | NS Record: ns72.domaincontrol.com. |
esmbiotech.co.uk. | NS | 3600 | NS Record: ns71.domaincontrol.com. |
esmbiotech.co.uk. | MX | 3600 | MX Record: 0 esmbiotech-co-uk.mail.protection.outlook.com. |
esmbiotech.co.uk. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
esmbiotech.co.uk. | TXT | 3600 | TXT Record: NETORGFT5334836.onmicrosoft.com |
ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH ESM BIOTECH More Welcome to ESM Biotech Welcome to ESM Biotech Welcome to ESM Biotech Welcome to ESM Biotech Contact Us Welcome to ESM Biotech Welcome to ESM Biotech Welcome to ESM Biotech Welcome to ESM Biotech Contact Us we invest in exceptional life science companies Neutraceuticals Profitable, dual listed nutraceutical firm in Australia, Europe and USA., with proprietary nutritional product formulations. Investment is for organic growth Allergy Immunology A Central European listed biotech firm immunology Investment is to complete Phase III trials on allergy therapy Skin Therapy An Australian and Western Europe listed biotech firm in skin treatment. Investment is to support final regulatory approval leading to rollout of commercial products Cancer Biomarkers Private North American firm in cancer diagnostics. Pre-IPO Investment to develop product readiness to support clinical trials leading to FDA |
HTTP/1.1 301 Moved Permanently location: https://esmbiotech.co.uk/ Vary: Accept-Encoding Server: DPS/1.13.2 X-SiteId: 4000 Set-Cookie: dps_site_id=4000; path=/ Date: Sun, 27 Mar 2022 08:40:09 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.13.2 x-siteid: 4000 set-cookie: dps_site_id=4000; path=/; secure date: Sun, 27 Mar 2022 08:40:09 GMT |